RNS Number : 8087M
Silence Therapeutics PLC
11 May 2015
 



TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES

 

1. Identity of the issuer or the underlying issuer
of existing shares to which voting rights are
attached:

Silence Therapeutics plc  

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

 

x

 

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached


An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments


An event changing the breakdown of voting rights:


Other (please specify):

CHANGE TO THE NUMBER OF VOTING RIGHTS IN ISSUE, FOLLOWING THE RECENT ADDITIONAL LISTING.

 

x

 

3. Full name of person(s) subject to the
notification obligation:

Aviva plc & its subsidiaries    

4. Full name of shareholder(s)
 (if different from 3.):

Registered Holder:

 

BNY Norwich Union Nominees Limited       169,007* 

 

Chase (GA Group) Nominees Limited        3,917,463*

                                                             

*denotes direct interest

 

Chase (GA Group) Nominees Limited           129,194

 

Chase Nominees Limited                                 72,658

 

Vidacos Nominees Limited                            170,654  

5. Date of the transaction and date on
which the threshold is crossed or
reached:

08 May 2015

6. Date on which issuer notified:

11 May 2015

7. Threshold(s) that is/are crossed or
reached:

4% to 5% Change at Direct Interest Level

<5% to >5% Change at Combined Interest Level

 

 

 

8. Notified details:

A: Voting rights attached to shares

Class/type of
shares


if possible using
the ISIN CODE

Situation previous
to the triggering
transaction

Resulting situation after the triggering transaction

Number
of
Shares

Number
of
Voting
Rights

Number
of shares

Number of voting
rights

% of  voting rights

Direct

Direct

Indirect

Direct

Indirect

Ordinary Shares

GB00B9GTXM62

2,301,157

2,301,157

4,458,976

4,086,470

372,506

5.85%

0.54%


 

 

 

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial
instrument

Expiration
date

Exercise/
Conversion Period

Number of voting
rights that may be
acquired if the
instrument is
exercised/ converted

% of voting
rights







 

 

 

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial
instrument

Exercise price

Expiration date

Exercise/
Conversion period

Number of voting rights instrument refers to

 

% of voting rights

 





 

 

Nominal

Delta



 

Total (A+B+C)

Number of voting rights

Percentage of voting rights

4,458,976

6.39%

 

9. Chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held, if applicable:

The voting rights are managed and controlled by Aviva Investors Global Services Limited, with the following chain of controlled undertakings:-

 

Aviva Investors Global Services Limited:

·      Aviva plc (Parent Company)

·      Aviva Group Holdings Limited (wholly owned subsidiary of Aviva plc)

·      Aviva Investors Holdings Limited (wholly owned subsidiary of Aviva Group Holdings Limited)

·      Aviva Investors Global Services Limited (wholly owned subsidiary of Aviva Investors Holdings Limited)

 

 

 


Proxy Voting:

10. Name of the proxy holder:

See Section 4

11. Number of voting rights proxy holder will cease
to hold:


12. Date on which proxy holder will cease to hold
voting rights:




13. Additional information:


Figures are based on a total number of voting rights of 69,801,624 as per the Company's 'Result of General Meeting and Additional Listing' announcement of 01 May 2015.

 

14. Contact name:

Neil Whittaker, Aviva plc

15. Contact telephone number:

01603 684420

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLUARSRVOAVAAR